EXAGEN INC. (XGN): Price and Financial Metrics
EXAGEN INC. (XGN)
Today's Latest Price: $16.13 USD
Updated Jan 26 4:00pm
Add XGN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 64 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
XGN Stock Summary
- With a one year PEG ratio of 0.62, Exagen Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 6.06% of US stocks.
- XGN's went public 1.36 years ago, making it older than just 1.22% of listed US stocks we're tracking.
- Of note is the ratio of Exagen Inc's sales and general administrative expense to its total operating expenses; 77.03% of US stocks have a lower such ratio.
- If you're looking for stocks that are quantitatively similar to Exagen Inc, a group of peers worth examining would be KIDS, SREV, TELA, ARTW, and HAYN.
- Visit XGN's SEC page to see the company's official filings. To visit the company's web site, go to avisetest.com.
XGN Stock Price Chart Interactive Chart >
XGN Price/Volume Stats
| Current price | $16.13 | 52-week high | $24.98 |
| Prev. close | $15.99 | 52-week low | $10.29 |
| Day low | $15.41 | Volume | 13,100 |
| Day high | $16.39 | Avg. volume | 38,394 |
| 50-day MA | $14.37 | Dividend yield | N/A |
| 200-day MA | $13.67 | Market Cap | 204.08M |
EXAGEN INC. (XGN) Company Bio
Exagen, Inc. is a commercial-stage diagnostics company. It engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. The company operates under the Avise brand.
Loading social stream, please wait...